Digital Health Startups

Anjo is an AI platform that uses data from smart wearables to continuously monitor physiological signals and detect early signs of allergic reactions or anaphylaxis. It provides remote monitoring, alerts, and allergy insights for families and individuals living with life-threatening allergies, and supplies data to physicians for care decisions.

1 investor

Anju Software provides software tools for biopharmaceutical companies and Contract Research Organizations (CROs) to manage and analyze clinical and life sciences data. Its products, such as TA Scan, aggregate disparate data sources to support clinical research and drug development.

1 investor

Annie is an AI "digital coworker" for dental practices that answers phone calls, books appointments, handles website chat, and runs automated recare follow-ups around the clock. It integrates with practice management software to schedule patients according to each office's rules, serving dental practices, DSOs, and partners.

1 investor

1 investor

AnthroMed Education is a therapy services provider that places and supports clinicians who deliver therapy to students with diverse needs in schools across the United States. It offers clinicians clinical mentorship, caseload guidance, continuing education, and a professional community.

1 investor

Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making. Its portfolio includes FDA-cleared ECG-AI algorithms, generative imaging applications, and real-time procedural support tools for use across diagnostic and intraprocedural cardiac care.

1 investor

AOBiome Therapeutics is a late-stage biotechnology company developing microbiome-based treatments for inflammatory skin conditions such as atopic dermatitis and pruritus. Its lead candidate, B244, uses a single strain of Ammonia Oxidizing Bacteria to moderate immune response by simultaneously down-regulating multiple inflammatory markers (IL-4, IL-5, IL-13, IL-31).

1 investor

Aparito offers Atom5, an electronic clinical outcome assessment (eCOA) platform that captures data from video assessments, voice, wearables, ePROs, telemedicine, and eConsent. The platform applies machine learning to provide real-time insights to clinical trial and research teams.

1 investor

Apex Infusion is a California-based provider of infusion therapy delivered in private suites, at home, and in physician offices, along with integrated pharmacy services. It serves patients and referring healthcare providers with clinical and administrative support for infusion treatments.

1 investor

APEX Labs is a pharmaceutical company developing, clinically evaluating, and commercializing psilocybin-based therapies for depression and PTSD, with a primary focus on veteran populations. It aims to enable physicians to prescribe its drug assets for critical unmet needs in mental health.

1 investor

ApolloCare provides technology-driven solutions for managing and administering copay, voucher, and patient assistance programs, serving pharmaceutical and healthcare clients. Its products help clients integrate prescription and patient program data with analytics to support the prescription journey.

1 investor

Apollo Sri Lanka coordinates access for patients in Sri Lanka to receive advanced medical treatment at Apollo Hospitals in India, handling consultation, medical report review, visa, and travel logistics. It focuses on services such as cancer care and proton beam therapy at internationally accredited facilities.

1 investor

apopitch is a pitch competition for startups in the pharmacy and healthcare sector, where a jury selects three finalists to present at the "München inspiriert" event organized by Alliance Healthcare Deutschland and GEHE. It is aimed at healthcare and pharmacy-focused startups in Germany.

1 investor

apoQlar develops HoloMedicine®, an extended-reality (XR) platform for hospitals that provides 3D CT/MRI reconstructions, surgical planning, remote surgical proctoring, and immersive medical teaching. It serves clinicians and medical institutions with an MDR Class IIa-certified Patient Viewer and an app ecosystem that integrates into existing hospital infrastructure via SSO and APIs.

1 investor

AposHealth offers Apos, an FDA-cleared, foot-worn medical device personalized to each patient's biomechanics to treat knee osteoarthritis, chronic hip pain, and non-specific back pain, delivered as an at-home program supervised by a licensed physical therapist. It serves adults with chronic musculoskeletal joint pain seeking to avoid surgery or reduce medication, with access through VA benefits, commercial insurance, FSA/HSA, and UK referral pathways.

1 investor

AppEase is a cloud-based platform that retrieves and structures digital health records in real time to speed up insurance underwriting and claims. It serves insurance carriers, advisors, and agents handling life, disability, long-term care, property, casualty, and workers' compensation applications and claims.

1 investor

RxPhoto provides HIPAA-compliant clinical photography software for capturing consistent before-and-after patient photos, along with digital forms, notes, and side-by-side comparisons. It is designed for aesthetic practices and medical spas to standardize documentation and support patient consultations.

1 investor

Apricity Health develops precision oncology solutions for drug discovery and development. The company was founded by physicians and scientists focused on improving cancer treatment outcomes.

1 investor

Apricot Health provides AI-powered documentation software that reduces paperwork burden for home health nurses and agencies. The platform helps agencies cut documentation time and improve operational efficiency across QA, referrals, and scheduling.

1 investor

Apriwell develops food supplements and dietary management products for digestive conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, bloating, and constipation, as well as migraine prevention. The company combines natural ingredients with scientific formulations and offers personal coaching with digestive and nutrition experts to consumers, primarily in Germany.

1 investor

Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.

1 investor

Aqua Endoscopy (Aqua Medical Inc.) develops medical device technology and conducts clinical trials to advance innovative endoscopic solutions. The company serves the medical device and healthcare sectors.

1 investor

Aquapass develops a non-invasive medical device that removes excess bodily fluid through the skin by activating the eccrine (sweat) glands, working independently of kidney function. It targets fluid overload in patients with heart failure and chronic or end-stage kidney disease, and holds two FDA Breakthrough Device Designations.

1 investor

ARSOLUTION develops Medar, a 3D and virtual reality anatomy education platform that lets students and instructors interactively examine organs such as the skull, brain, heart, and fetus across VR headsets, desktops, tablets, and smartphones. It provides management panels for tracking student performance and integrates augmented reality with Canvas LMS for medical and academic institutions.

1 investor